Post-approval studies (Phase 4)Study completedNCT01238575
What this trial is testing
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Who this might be right for
Pervasive Development Disorders
Yale University 62
Showing 20 of 86 results